Vincenzo Dattilo

1.2k total citations
36 papers, 889 citations indexed

About

Vincenzo Dattilo is a scholar working on Molecular Biology, Immunology and Cancer Research. According to data from OpenAlex, Vincenzo Dattilo has authored 36 papers receiving a total of 889 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 8 papers in Immunology and 7 papers in Cancer Research. Recurrent topics in Vincenzo Dattilo's work include MicroRNA in disease regulation (7 papers), Extracellular vesicles in disease (5 papers) and ATP Synthase and ATPases Research (4 papers). Vincenzo Dattilo is often cited by papers focused on MicroRNA in disease regulation (7 papers), Extracellular vesicles in disease (5 papers) and ATP Synthase and ATPases Research (4 papers). Vincenzo Dattilo collaborates with scholars based in Italy, United States and United Kingdom. Vincenzo Dattilo's co-authors include Nicola Perrotti, Rosario Amato, Lucia D’Antona, Rodolfo Iuliano, Silvia Schenone, Selena Mimmi, Francesco Trapasso, Stefano Alcaro, Enrico Iaccino and Francesco Ortuso and has published in prestigious journals such as Scientific Reports, The FASEB Journal and Nanoscale.

In The Last Decade

Vincenzo Dattilo

36 papers receiving 877 citations

Peers

Countries citing papers authored by Vincenzo Dattilo

Since Specialization

Citations

This map shows the geographic impact of Vincenzo Dattilo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vincenzo Dattilo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vincenzo Dattilo more than expected).

Fields of papers citing papers by Vincenzo Dattilo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vincenzo Dattilo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vincenzo Dattilo. The network helps show where Vincenzo Dattilo may publish in the future.

Co-authorship network of co-authors of Vincenzo Dattilo

This figure shows the co-authorship network connecting the top 25 collaborators of Vincenzo Dattilo. A scholar is included among the top collaborators of Vincenzo Dattilo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vincenzo Dattilo. Vincenzo Dattilo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Plasma microRNA Levels After Electroconvulsive Therapy in Treatment-Resistant Depressed Patients 2025 ·Journal of Ect ·(unknown), Vincenzo Dattilo, Marco Bortolomasi, (unknown), Maria Abate, (unknown), (unknown), Rosana Carvalho Silva, Massimo Gennarelli, Luisella Bocchio‐Chiavetto, Alessandra Minelli	2
2	The IL-23R and Its Genetic Variants: A Hitherto Unforeseen Bridge Between the Immune System and Cancer Development 2024 ·Cancers ·(unknown), (unknown), Vincenzo Dattilo, (unknown), Francesco Trapasso, Rosario Amato	2
3	Transcriptional Modulation of Stress-Related Genes in Association with Early Life Stress Exposure and Trauma-Focused Psychotherapy in Treatment-Resistant Depression Patients 2023 ·Journal of EMDR Practice and Research ·Rosana Carvalho Silva, Vincenzo Dattilo, (unknown), Monica Mazzelli, Elisabetta Maffioletti, (unknown), Marco Bortolomasi, Annamaria Cattaneo, Massimo Gennarelli, Alessandra Minelli	2
4	LRRK2 Kinase Inhibition Attenuates Astrocytic Activation in Response to Amyloid β1-42 Fibrils 2023 ·Biomolecules ·Alice Filippini, Valentina Salvi, Vincenzo Dattilo, Chiara Magri, (unknown), Robert Veerhuis, Daniela Bosisio, Massimo Gennarelli, Isabella Russo	7
5	RANBP1 (RAN Binding Protein 1): The Missing Genetic Piece in Cancer Pathophysiology and Other Complex Diseases 2023 ·Cancers ·(unknown), (unknown), Vincenzo Dattilo, Lucia D’Antona, (unknown), Rodolfo Iuliano, Francesco Trapasso, Nicola Perrotti, Rosario Amato	16
6	SARS CoV-2 spike protein-guided exosome isolation facilitates detection of potential miRNA biomarkers in COVID-19 infections 2023 ·Clinical Chemistry and Laboratory Medicine (CCLM) ·Selena Mimmi, (unknown), (unknown), Erika Cione, (unknown), Annamaria Aloisio, Domenico Maisano, Anna Maria Tolomeo, Vincenzo Dattilo, Rosaria Lionello, Antonella Fioravanti, Antonio Di Loria, Angela Quirino, Nadia Marascio, Alessandro Russo, Enrico Maria Trecarichi, Giovanni Matera, Ileana Quinto, Carlo Torti, Enrico Iaccino	27
7	RANBP1, a member of the nuclear-cytoplasmic trafficking-regulator complex, is the terminal-striking point of the SGK1-dependent Th17+ pathological differentiation 2023 ·Frontiers in Immunology ·(unknown), Vincenzo Dattilo, Lucia D’Antona, Emanuela Chiarella, Rossana Tallerico, (unknown), (unknown), Rodolfo Iuliano, Francesco Trapasso, Nicola Perrotti, Rosario Amato	6
8	Th17-Gene Expression Profile in Patients with Chronic Venous Disease and Venous Ulcers: Genetic Modulations and Preliminary Clinical Evidence 2022 ·Biomolecules ·Rosario Amato, Vincenzo Dattilo, (unknown), Lucia D’Antona, Rodolfo Iuliano, Francesco Trapasso, Nicola Perrotti, Davide Costa, Nicola Ielapi, Tommaso Francesco Aiello, Michele Provenzano, Umberto Marcello Bracale, Michele Andreucci, Raffaele Serra	8
9	Spotlight on a Short-Time Treatment with the IL-4/IL-13 Receptor Blocker in Patients with CRSwNP: microRNAs Modulations and Preliminary Clinical Evidence 2022 ·Genes ·Selena Mimmi, Nicola Lombardo, Domenico Maisano, (unknown), Corrado Pelaia, Girolamo Pelaia, Marta Greco, Daniela Foti, Vincenzo Dattilo, Enrico Iaccino	8
10	Genome-wide association studies on Northern Italy isolated populations provide further support concerning genetic susceptibility for major depressive disorder 2022 ·The World Journal of Biological Psychiatry ·Vincenzo Dattilo, Sheila Ulivi, Alessandra Minelli, Martina La Bianca, Edoardo Giacopuzzi, Marco Bortolomasi, Stefano Bignotti, Massimo Gennarelli, Paolo Gasparini, Maria Pina Concas	5
11	A Novel Splicing Variant of COL2A1 in a Fetus with Achondrogenesis Type II: Interpretation of Pathogenicity of In-Frame Deletions 2021 ·Genes ·(unknown), (unknown), (unknown), Vincenzo Dattilo, (unknown), Carmela Votino, Emanuele Bellacchio, Nicola Perrotti, Sabrina Giglio, Rodolfo Iuliano	6
12	Clinical validation of a combinatorial PharmAcogeNomic approach in major Depressive disorder: an Observational prospective RAndomized, participant and rater-blinded, controlled trial (PANDORA trial) 2021 ·Trials ·Alessandra Minelli, Sergio Barlati, (unknown), Stefano Bignotti, Vincenzo Dattilo, (unknown), Elisabetta Maffioletti, Edoardo Giacopuzzi, Vincenza Santoro, (unknown), Chiara Cobelli, Chiara Magri, (unknown), Luisella Bocchio‐Chiavetto, Edoardo Spina, Antonio Vita, Massimo Gennarelli	7
13	Predominant VH1-69 IgBCR Clones Show Higher Expression of CD5 in Heterogeneous Chronic Lymphocytic Leukemia Populations 2021 ·Frontiers in Oncology ·Domenico Maisano, Enrico Iaccino, Alessandro d’Ambrosio, Federico Chiurazzi, Vincenzo Dattilo, Mariangela Scalise, Massimo Gentile, Eleonora Vecchio, (unknown), Annamaria Aloisio, (unknown), Giuseppe Fiume, Ileana Quinto, Selena Mimmi	1
14	Expression of Serum Exosomal miRNA 122 and Lipoprotein Levels in Dogs Naturally Infected by Leishmania infantum: A Preliminary Study 2020 ·Animals ·Antonio Di Loria, Vincenzo Dattilo, Domenico Santoro, Jacopo Guccione, (unknown), Paolo Ciaramella, Marinella Pirozzi, Enrico Iaccino	26
15	Review about the multi-target profile of resveratrol and its implication in the SGK1 inhibition 2019 ·European Journal of Medicinal Chemistry ·(unknown), Federica Moraca, Lucia D’Antona, Vincenzo Dattilo, (unknown), Antonio Lupia, Giosuè Costa, Francesco Ortuso, Rodolfo Iuliano, Francesco Trapasso, Rosario Amato, Stefano Alcaro, Nicola Perrotti	24
16	In Preclinical Model of Ovarian Cancer, the SGK1 Inhibitor SI113 Counteracts the Development of Paclitaxel Resistance and Restores Drug Sensitivity 2019 ·Translational Oncology ·Lucia D’Antona, Vincenzo Dattilo, (unknown), Domenica Scumaci, (unknown), Francesca Musumeci, (unknown), Silvia Schenone, Rossana Tallerico, (unknown), Nicola Costa, Rodolfo Iuliano, Giovanni Cuda, Rosario Amato, Nicola Perrotti	25
17	The SGK1 Kinase Inhibitor SI113 Sensitizes Theranostic Effects of the 64CuCl2 in Human Glioblastoma Multiforme Cells 2017 ·Cellular Physiology and Biochemistry ·(unknown), (unknown), Vincenzo Dattilo, (unknown), Ferdinando Calabria, Lucia D’Antona, Silvia Schenone, Francesca Musumeci, Cataldo Bianco, Nicola Perrotti, Rosario Amato, Giuseppe Lucio Cascini	32
18	SGK1 affects RAN/RANBP1/RANGAP1 via SP1 to play a critical role in pre-miRNA nuclear export: a new route of epigenomic regulation 2017 ·Scientific Reports ·Vincenzo Dattilo, Lucia D’Antona, (unknown), Mjriam Capula, (unknown), Rodolfo Iuliano, Silvia Schenone, Sante Roperto, Cataldo Bianco, Nicola Perrotti, Rosario Amato	29
19	SGK1, the New Player in the Game of Resistance: Chemo-Radio Molecular Target and Strategy for Inhibition 2016 ·Cellular Physiology and Biochemistry ·(unknown), Vincenzo Dattilo, Lucia D’Antona, Miranda Menniti, Cataldo Bianco, Francesco Ortuso, Stefano Alcaro, Silvia Schenone, Nicola Perrotti, Rosario Amato	69
20	Early molecular and behavioral response to lipopolysaccharide in the WAG/Rij rat model of absence epilepsy and depressive-like behavior, involves interplay between AMPK, AKT/mTOR pathways and neuroinflammatory cytokine release 2014 ·Brain Behavior and Immunity ·Emilio Russo, Francesco Andreozzi, Rodolfo Iuliano, Vincenzo Dattilo, Teresa Procopio, Giuseppe Fiume, Selena Mimmi, Nicola Perrotti, Rita Citraro, Giorgio Sesti, Andrew Constanti, Giovambattista De Sarro	78

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact